The challenges of connecting molecular changes to tissue structure and highlights the potential of multifractal frameworks to quantify complex biological patterns ...
SMA mutations disrupt spinal cord development, with fewer nerve cells in early stages. SMN protein deficiency leads to a mesodermal fate bias, with fewer motor neurons. Increasing SOX2 pathway ...
Author(s)Leilani Alvarez, DVM, DACVSMR, CVA, CCRT, Abi Bautista-Alejandre, Assistant Editor Struggling to localize forelimb lameness? This Q&A with Leilani Alvarez, DVM, DACVSMR, CVA, CCRT, head of ...
Osteoporosis is a serious condition affecting millions worldwide. While available treatments can slow the condition's progress, there's no way to reverse or cure the condition. Current treatments also ...
Single-cell transcriptomics data from mouse bone-relevant cells was used to inform human bone mineral density genome-wide association studies and prioritize genetic targets with potential causal roles ...
Researchers develop a radiomics-based machine learning model to identify patients with traumatic brain injury at risk ...
Osteoarthritis is usually framed as the price of just getting older. Many people imagine a knee that slowly wears down, then never recovers. That picture is familiar, yet it is too simple.
Traumatic brain injury (TBI) can trigger dangerous swelling inside the skull, raising intracranial pressure to life-threatening levels even after ...
First Nations leaders on Tuesday unveiled five items repatriated to their communities after being held at the Vatican for more than a century.
Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of ...
Orthocell is taking Remplir into the huge US market, where even a tiny slice of the market could push the company toward profitability.
For years, we suspected that Alvarezsaurids underwent a rare process of evolutionary miniaturization directly coupled to a ...